Loading…
BioSpring acquired 30,000 sq m of land in Offenbach, Germany to build three new production units for oligonucleotide-based active pharmaceutical ingredients. The company plans to invest over €100 million and create 1,500 jobs.
| Site | Largest | Latest |
|---|---|---|
| Offenbach, Germany | $106.0M | 2022-12-21 |